Valuation: AngioDynamics, Inc.

Market Cap 638M 556M 525M 477M 894M 61.24B 898M 6.29B 2.43B 31.13B 2.4B 2.34B 100B P/E 2027 *
-29.3x
P/E 2028 * -52.6x
Enterprise Value 638M 556M 525M 477M 894M 61.24B 898M 6.29B 2.43B 31.13B 2.4B 2.34B 100B EV / Sales 2027 *
1.89x
EV / Sales 2028 * 1.8x
Free-Float
86.06%
Yield 2027 *
-
Yield 2028 * -
1 day+0.46%
1 week+1.11%
Current month-4.28%
1 month-2.40%
3 months+27.08%
6 months+48.32%
Current year+20.25%
1 week 14.97
Extreme 14.97
15.92
1 month 14.85
Extreme 14.85
16.29
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2016
Director of Finance/CFO 51 22/10/2019
Chief Tech/Sci/R&D Officer - 31/12/2016
Director TitleAgeSince
Chairman 65 28/04/2014
Director/Board Member 67 28/01/2007
Director/Board Member 62 31/03/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Sell

General Counsel

-23,370 0.0565%
22/07/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/07/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%+1.11%+43.36%+117.16% 638M
+0.37%+0.65%-24.57%+2.32% 178B
-0.69%+1.29%-3.10%+13.07% 118B
-0.20%-3.98%+6.47%+68.94% 58.92B
-0.24%+1.74%-3.26%-32.27% 49.29B
-0.22%-0.37%+10.27%+42.75% 48.17B
+1.61%+7.61%+32.47%-3.54% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.17%-5.73% 25.5B
+1.16%+8.91%+8.41%-13.62% 22.1B
Average -0.04%+1.59%+12.47%+21.01% 56.15B
Weighted average by Cap. -0.07%+0.95%-3.05%+11.23%

Financials

2027 *2028 *
Net sales 337M 294M 278M 252M 473M 32.37B 475M 3.33B 1.28B 16.46B 1.27B 1.24B 52.95B 355M 310M 292M 266M 498M 34.08B 500M 3.5B 1.35B 17.33B 1.33B 1.3B 55.75B
Net income -22.3M -19.45M -18.36M -16.67M -31.24M -2.14B -31.37M -220M -84.87M -1.09B -83.77M -81.91M -3.5B -12.67M -11.05M -10.43M -9.47M -17.74M -1.22B -17.82M -125M -48.21M -618M -47.58M -46.53M -1.99B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
18/09/26 US$15.44 +0.46% 1,012,597
17/09/26 US$15.37 -0.58% 558,681
16/09/26 US$15.46 -1.40% 469,643
15/09/26 US$15.68 +1.10% 661,544
14/09/26 US$15.51 +1.57% 389,330
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.44USD
Average target price
20.00USD
Spread / Average Target
+29.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!